Aurobindo Pharma Latest News

  1. Aurobindo Pharma has informed about a press release titled ‘Aurobindo Pharma receives USFDA Approval for Sevelamer Carbonate tablets’.

    The above information is a part of company’s filings submitted to BSE....

    Date:19-07-2017
  2. Sevelamer Carbonate tablets is indicated for the control of serum phosphorus in patients with CKD on dialysis
    Date:19-07-2017
  3. Sevelamer Carbonate tablets is indicated for the control of serum phosphorus in patients with CKD on dialysis
    Date:19-07-2017
  4. The Hyderabad-based firm is working on plans to launch cancer treatment and injectable products in the European Union
    Date:03-07-2017
  5. The Hyderabad-based firm is working on plans to launch cancer treatment and injectable products in the European Union
    Date:03-07-2017
  6. Aurobindo Pharma has informed about press release titled ‘Aurobindo Pharma receives USFDA Approval for Sevelamer Carbonate Oral Suspension’.

    The above information is a part of company’s f...

    Date:15-06-2017
  7. The approved product has an estimated market size of $140 million for the twelve months ending April 2017
    Date:15-06-2017
  8. The approved product has an estimated market size of $140 million for the twelve months ending April 2017
    Date:15-06-2017
  9. The addressable market for the company’s total 429 ANDAs has been pegged at $91 billion
    Date:08-06-2017
  10. The addressable market for the company’s total 429 ANDAs has been pegged at $91 billion
    Date:08-06-2017
Return to Top
Connect with us Facebook
Connect with us Facebook
Connect with us Linkedin
Connect with us Pintrest
Connect with us Google Plus
Connect with us You Tube
Connect with us Mobile App
Request a Call Back
We will guide you on how to find
the Right stocks at the Right prices.
Mobile
Invalid Mobile Number
x
Thank you for
contacting us.
We will call you
shortly.